CINECA IRIS Institutional Research Information System

BOGAZZI, FAUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.050
AS - Asia 7.895
EU - Europa 5.223
SA - Sud America 922
AF - Africa 357
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 30.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.546
SG - Singapore 2.460
CN - Cina 2.123
IT - Italia 1.439
HK - Hong Kong 1.420
SE - Svezia 830
BR - Brasile 759
DE - Germania 714
VN - Vietnam 652
BG - Bulgaria 553
TR - Turchia 416
CA - Canada 364
GB - Regno Unito 314
FI - Finlandia 298
UA - Ucraina 264
RU - Federazione Russa 258
FR - Francia 246
KR - Corea 170
IN - India 156
SN - Senegal 119
CH - Svizzera 96
JP - Giappone 92
CI - Costa d'Avorio 73
BD - Bangladesh 66
MX - Messico 64
IQ - Iraq 54
SA - Arabia Saudita 41
ZA - Sudafrica 40
AT - Austria 37
AR - Argentina 35
BE - Belgio 30
NL - Olanda 30
PK - Pakistan 29
UZ - Uzbekistan 28
ID - Indonesia 26
VE - Venezuela 26
EC - Ecuador 25
KE - Kenya 23
PH - Filippine 22
CO - Colombia 21
ES - Italia 21
EG - Egitto 18
PL - Polonia 18
DZ - Algeria 17
UY - Uruguay 17
GR - Grecia 16
AU - Australia 15
JM - Giamaica 15
MY - Malesia 15
LB - Libano 14
TN - Tunisia 13
AL - Albania 12
MA - Marocco 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
CZ - Repubblica Ceca 11
NP - Nepal 11
IE - Irlanda 10
TT - Trinidad e Tobago 10
BJ - Benin 9
ET - Etiopia 9
JO - Giordania 9
OM - Oman 9
HN - Honduras 8
AZ - Azerbaigian 7
BB - Barbados 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
PE - Perù 7
SY - Repubblica araba siriana 7
IL - Israele 6
NG - Nigeria 6
BO - Bolivia 5
CR - Costa Rica 5
EU - Europa 5
AM - Armenia 4
BH - Bahrain 4
CG - Congo 4
KG - Kirghizistan 4
KW - Kuwait 4
LY - Libia 4
NI - Nicaragua 4
RS - Serbia 4
TH - Thailandia 4
AO - Angola 3
BM - Bermuda 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
GE - Georgia 2
GH - Ghana 2
GY - Guiana 2
Totale 30.426
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.765
Ashburn 1.665
Fairfield 1.432
Singapore 1.343
Hong Kong 1.301
Ann Arbor 976
Chandler 963
Houston 954
San Jose 729
Dallas 669
Santa Clara 613
Seattle 605
Milan 588
Sofia 550
Cambridge 523
Beijing 485
Wilmington 470
Shanghai 433
Jacksonville 357
New York 348
Ottawa 303
Izmir 268
Boardman 262
Hefei 223
Princeton 218
Los Angeles 211
Lawrence 207
Medford 188
Nanjing 174
Lauterbourg 171
Seoul 166
Ho Chi Minh City 155
Des Moines 139
Hanoi 121
Dakar 118
Munich 118
Istanbul 115
Bern 95
Florence 88
Serra 88
Dearborn 87
Dong Ket 85
Bremen 84
Tokyo 80
Buffalo 79
Nanchang 79
Jüchen 77
Abidjan 73
Redondo Beach 70
San Diego 70
Rome 67
Frankfurt am Main 60
São Paulo 59
Turku 55
Kunming 49
Lancaster 48
Helsinki 46
Council Bluffs 43
Pisa 40
Boulder 38
Changsha 37
Hebei 35
Tianjin 35
The Dalles 34
Redwood City 33
Shenyang 32
Düsseldorf 30
London 29
Washington 29
Orem 27
Columbus 26
Jiaxing 26
Hangzhou 25
Auburn Hills 24
Brussels 24
Chicago 24
Dhaka 24
Falls Church 24
Ogden 24
Pune 24
Detroit 23
Vienna 23
Tashkent 22
Da Nang 21
Marseille 21
Nairobi 21
Rio de Janeiro 21
Haiphong 20
Falkenstein 19
Manchester 19
Norwalk 19
Brasília 18
Jeddah 18
Belo Horizonte 17
Guangzhou 17
Johannesburg 17
Quanzhou 17
Warsaw 17
Curitiba 16
Jinan 16
Totale 22.434
Salva come PNG Salva come JPEG
Nome #
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 271
The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type 244
FT-IR Microspectroscopy application in cardiac Hypertrophy 241
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 239
REGULATION OF CARDIAC FATTY ACID METABOLISM IN TRANSGENIC MICE OVEREXPRESSING BOVINE GROWTH HORMONE 236
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 218
Glucocorticoid response in amiodarone-induced thyrotoxicosis due to destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations 216
Growth Hormone Is Necessary for the p53-Mediated, Obesity-Induced Insulin Resistance in Male C57BL/6J × CBA Mice 216
uptake of amiodarone by thyroidal and non-thyroidal cell lines 215
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 214
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 212
Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis 206
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 203
AMIODARONE-INDUCED THYROTOXICOSIS AND THYROID STORM 200
Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature 199
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 199
More on smoking habits and Graves' ophthalmopathy 197
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? 196
Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin 196
Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study 196
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 196
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 194
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 191
Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study 191
Glucocorticoid therapy of Graves' ophthalmopathy 190
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 188
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy 188
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 186
The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells 185
IMPAIRED LEFT VENTRICULAR DIASTOLIC FUNCTION IN ACROMEGALIC PATIENTS WITHOUT CLINICAL SIGNS OF HEART FAILURE: A 2D STRAIN ECHOCARDIOGRAPHIC ANALYSIS 185
Amiodarone-Induced Thyrotoxicosis 184
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease 183
The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996 183
Lack of nocturnal serum thyrotropin surge after surgery 182
Identification, treatment and management of cardiovascular risks in patients with acromegaly 180
Serum Insulin-Like Growth Factor-1 Concentrations Are Reduced in Severely Obese Women and Raise After Weight Loss Induced by Laparoscopic Adjustable Gastric Banding 180
Bone and joint alterations in acromegaly 179
Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism 179
Lower Prolactin Levels During Cabergoline Treatment are Associated to Tumor Shrinkage in Prolactin Secreting Pituitary Adenoma. 179
Large vestibular aqueduct syndrome: audiological, radiological, clinical, and genetic features 178
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 175
Studies on the occurrence of ophthalmopathy in Graves' disease 173
Rare causes of thyrotoxicosis 173
Adverse effects of thyroid hormone preparations and antithyroid drugs 172
Early pre-clinical abnormalities of systolic strain and strain-rate in acromegalic heart: a color Doppler myocardial imaging study 172
The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines 172
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 172
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists 171
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy 171
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 171
Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why 170
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial 170
Cardiac extrinsic apoptotic pathway is silent in young but activated in elder mice overexpressing bovine GH: interplay with the intrinsic pathway 170
DISEASE ACTIVITY AND LIFESTYLE INFLUENCE COMORBIDITIES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ACROMEGALY 170
Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy 169
VITAMIN D STATUS MAY CONTRIBUTE TO SERUM IGF1 CONCENTRATIONS IN HEALTHY SUBJECTS 169
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 169
Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy 168
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? 168
The beneficial effect of acromegaly control on blood pressure values in normotensive patients 168
Orbital irradiation in the treatment of Graves' ophthalmopathy 167
A novel mutation in the pendrin gene associated with the Pendred’s syndrome 167
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 167
Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non- autoimmune thyroid diseases 165
Long-Term outcome of patients with type 2 amiodarone induced thyrotoxicosis 163
Pendrin does not increase sulfate uptake in mammalian COS-7 cells 163
Early surgery: a favorable prognosticator in amiodarone-induced thyrotoxicosis-a single-center experience with 53 cases 162
Orbital decompression for severe Graves' ophthalmopathy. Results of a three-wall operative technique 162
Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction 161
COMPARISON OF COLONOSCOPY AND FECAL OCCULT BLOOD TESTING AS A FIRST-LINE SCREENING OF COLONIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED ACROMEGALY 161
Abnormal expression of PPAR gamma isoforms in the subcutaneos adipose tissue of patients with Cushing's disease 159
Cigarette smoking and the thyroid 158
Prostate-specific antigen is increased in female patients with Cushing's disease 157
Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery 157
Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct 156
Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease 155
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 155
Peroxisome proliferator-activated receptor (PPAR)γ is highly expressed in normal human pituitary gland 153
Identification of factors affecting the response to glucocorticoids in patients with amiodarone-induced thyrotoxicosis 152
Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects 152
A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor 151
Apoptosis is reduced in the colonic mucosa of patients with acromegaly 151
Surgical Treatment of Neuroendocrine Tumors of the Pancreas: Results and Prognostic Factors 150
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography 149
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 149
Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study 148
Role of cytokines in the pathogenesis of the euthyroid sick syndrome 148
Ectopic Spleens in the Tail of the Pancreas Mimicking Multifocal Neuroendocrine Tumors in a Patient with History of Endocrine Neoplasia. A Case Report 148
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly 147
Long-term outcome of patients with type 2 amiodarone-induced thyrotoxicosis 146
MPAIRED LEFT VENTRICULAR DIASTOLIC FUNCTION IN ACROMEGALIC PATIENTS WITHOUT CLINICAL SIGNS OF HEART FAILURE: A 2D STRAIN ECHOCARDIOGRAPHIC ANALYSIS 144
Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies 143
Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma 142
ACROSTUDY: the Italian experience 139
Amiodarone-induced thyrotoxicosis 137
Pegvisomant in acromegaly: an update 137
[Amiodarone and the thyroid] 137
Approach to the patient with amiodarone-induced thyrotoxicosis 135
IOPANOIC ACID RAPIDLY CONTROLS TYPE 1 AMIODARONE-INDUCED THYROITOXICOSIS TO THYROIDECTOMY 134
Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no? 134
Totale 17.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 0 0 232
2021/20222.170 25 89 30 153 482 300 35 102 170 68 107 609
2022/20232.560 324 237 150 304 285 355 9 237 507 7 120 25
2023/20242.165 303 272 334 162 331 369 73 63 24 15 39 180
2024/20256.408 25 241 37 343 431 549 473 398 686 864 668 1.693
2025/20266.247 462 829 790 391 658 632 1.182 227 267 567 189 53
Totale 30.727